🇺🇸 Pyrantel Pamoate in United States

39 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Adverse Event — 17 reports (43.59%)
  2. Drug Ineffective — 4 reports (10.26%)
  3. Enterobiasis — 4 reports (10.26%)
  4. Headache — 3 reports (7.69%)
  5. Helminthic Infection — 3 reports (7.69%)
  6. Treatment Failure — 3 reports (7.69%)
  7. Inappropriate Schedule Of Product Administration — 2 reports (5.13%)
  8. Accident At Work — 1 report (2.56%)
  9. Accidental Overdose — 1 report (2.56%)
  10. Anxiety — 1 report (2.56%)

Source database →

Pyrantel Pamoate in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Pyrantel Pamoate approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Pyrantel Pamoate in United States?

Swiss Tropical & Public Health Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.